GO:0045125 bioactive lipid receptor activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045125 (bioactive lipid receptor activity) is a molecular function that combines with a bioactive lipid and transmits the signal across the membrane by activating an associated heterotrimeric G-protein.
• Bioactive lipids are lipid molecules whose changes in concentration produce functional consequences in cellular processes, including inflammation, immunity, and metabolism.
• Receptors with this activity couple ligand binding to GDP/GTP exchange on the G-alpha subunit, initiating downstream signaling cascades.
• Key endogenous bioactive lipids include lysophospholipids, endocannabinoids, eicosanoids, and docosahexaenoic acid-derived mediators.
• Dysregulation of bioactive lipid receptor activity is implicated in metabolic disorders, inflammatory diseases, and cancer.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal dissection of receptor function in disease.
Description
Bioactive lipid receptor activity (GO:0045125) defines a molecular function in which a receptor binds a bioactive lipid and transmits a signal across the membrane by activating an associated heterotrimeric G-protein, promoting GDP-to-GTP exchange on the alpha subunit. Bioactive lipids are lipid molecules whose level changes produce functional consequences in diverse cellular processes, including inflammation, immunity, and metabolism. This activity is therefore a central node connecting lipid metabolism to signal transduction. Researchers study GO:0045125 to understand how lipid mediators such as lysophospholipids, endocannabinoids, eicosanoids, and docosahexaenoic acid-derived metabolites control cell behavior. Because these receptors are G-protein-coupled, their activation triggers canonical downstream pathways that can be interrogated genetically and pharmacologically. The term is also relevant to disease mechanisms: bioactive lipid signaling is dysregulated in metabolic and inflammatory conditions, and natural compounds that modulate lipid-sensing pathways show therapeutic potential in fatty liver disease and diabetes models. Consequently, GO:0045125 provides a framework for linking lipid chemistry to receptor pharmacology and to organismal physiology.
bioactive lipid receptor activity At A Glance
| GO ID | GO:0045125 |
|---|---|
| GO term | bioactive lipid receptor activity |
| Ontology | molecular_function |
| Synonym | none |
| Major function | Binding a bioactive lipid and activating an associated heterotrimeric G-protein by promoting GDP/GTP exchange on the alpha subunit |
| Ligand class | Bioactive lipids, including lysophospholipids, endocannabinoids, eicosanoids, and docosahexaenoic acid-derived mediators |
| Signaling output | G-protein activation and downstream signal transduction |
| Representative receptors | G-protein-coupled receptors for bioactive lipids, such as lysophospholipid and endocannabinoid receptors |
| Disease relevance | Metabolic disorders, inflammation, and cancer |
What Is GO:0045125?
GO:0045125 (bioactive lipid receptor activity) is a molecular function defined as combining with a bioactive lipid and transmitting the signal across the membrane by activating an associated G-protein; this promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex. A bioactive lipid is a lipid for which changes in lipid levels result in functional consequences in a variety of cellular processes. In practice, this means the receptor must both bind a lipid ligand and couple that binding to heterotrimeric G-protein activation.
Why Is bioactive lipid receptor activity Important in Cell Biology?
GO:0045125 is important because it defines the molecular interface where lipid signals are converted into G-protein-mediated cellular responses, a process that controls inflammation, immunity, and metabolic homeostasis. Dysregulated bioactive lipid signaling contributes to fatty liver disease, type 2 diabetes, and other metabolic pathologies, and experimental modulation of lipid-sensing pathways can improve insulin sensitivity and lipid homeostasis in vivo. Understanding this activity therefore supports target discovery and the development of therapeutics that act on lipid-mediated signaling.
• Connects lipid metabolism to heterotrimeric G-protein signaling.
• Controls inflammatory and immune responses through bioactive lipid mediators.
• Contributes to metabolic regulation, including insulin sensitivity and glucose/lipid homeostasis.
• Is implicated in non-alcoholic fatty liver disease and hepatic lipid metabolism.
• Provides mechanistic insight into how dietary and endogenous lipids affect cell signaling.
• Enables pharmacological targeting of lipid-sensing receptors for therapeutic benefit.
• Supports biomarker and target discovery in metabolic and inflammatory diseases.
• Can be dissected genetically using CRISPR-based models of receptor genes.
Molecular Mechanism of bioactive lipid receptor activity
Ligand recognition and binding
In simple terms: The receptor first grabs a lipid messenger molecule.
The function begins when a bioactive lipid, such as a lysophospholipid, endocannabinoid, eicosanoid, or docosahexaenoic acid-derived mediator, binds to the receptor. Bioactive lipids are defined by the fact that changes in their levels produce functional consequences in cellular processes, making ligand availability a key determinant of receptor output.
Conformational activation of the receptor
In simple terms: Binding changes the receptor's shape so it can activate a partner protein.
Ligand binding stabilizes an active receptor conformation that is competent to engage an associated heterotrimeric G-protein. This step is the structural bridge between lipid chemistry and signal transduction, and it is the defining feature of GO:0045125.
G-protein activation and GDP/GTP exchange
In simple terms: The receptor flips a molecular switch on the G-protein.
The activated receptor promotes the exchange of GDP for GTP on the alpha subunit of the heterotrimeric G-protein complex. This nucleotide exchange is the core catalytic event of the molecular function and initiates downstream signaling.
Downstream signal propagation
In simple terms: The switched-on G-protein passes the message inside the cell.
GTP-bound G-alpha subunits and released G-beta/gamma dimers propagate the signal to downstream effectors, translating the original lipid cue into cellular responses. This propagation underlies the physiological impact of bioactive lipid receptor activity in inflammation, immunity, and metabolism.
Integration with lipid metabolic pathways
In simple terms: The receptor's activity depends on the surrounding lipid environment.
Because the ligands are bioactive lipids, receptor output is shaped by lipid metabolic pathways that produce and degrade these mediators. For example, docosahexaenoic acid-derived neurolipids and other lipid mediators influence receptor-dependent signaling, linking lipid metabolism to receptor function.
Key Genes Involved in GO:0045125 bioactive lipid receptor activity
The following genes and proteins represent major nodes in bioactive lipid receptor activity and its downstream signaling, based on published studies of lipid-sensing pathways and G-protein-coupled receptor biology.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ADIPOR1 | Adiponectin receptor 1, a lipid-sensing receptor that activates AMPK signaling | Target for non-alcoholic fatty liver disease and metabolic regulation |
| PPARG | Nuclear receptor controlling lipid and glucose homeostasis | Central to insulin sensitivity and lipid metabolism |
| FGF21 | Metabolic hormone downstream of PPARγ signaling | Mediates glucose/lipid homeostasis in diabetes models |
| SLC2A2 (GLUT2) | Glucose transporter regulated by PPARγ-FGF21 signaling | Relevant to insulin sensitivity and glucose homeostasis |
| RXRA | Retinoid X receptor alpha, partner in PPAR-RXR signaling | Implicated in diabetic liver lipid metabolism |
| PPARA | Peroxisome proliferator-activated receptor alpha | Regulates lipid metabolism in diabetic mouse liver |
| TRPV1 | Ion channel modulated by endogenous bioactive lipids | Structural model for lipid-receptor modulation |
| CNR1 | Cannabinoid receptor 1, a G-protein-coupled receptor for endocannabinoids | Prototype for bioactive lipid receptor activity |
| CNR2 | Cannabinoid receptor 2, a G-protein-coupled receptor for endocannabinoids | Immune and inflammatory signaling |
| LPAR1 | Lysophosphatidic acid receptor 1, a G-protein-coupled receptor | Lysophospholipid signaling and cell migration |
| S1PR1 | Sphingosine-1-phosphate receptor 1, a G-protein-coupled receptor | Lysophospholipid signaling in immunity |
| PTGS2 (COX-2) | Enzyme producing eicosanoid bioactive lipids | Inflammatory lipid mediator synthesis |
| ALOX5 | Lipoxygenase producing leukotriene bioactive lipids | Inflammatory and immune regulation |
| PLA2G4A | Phospholipase A2 releasing arachidonic acid for lipid mediator synthesis | Upstream of eicosanoid production |
| GNAI1 | G-protein alpha subunit coupled to bioactive lipid receptors | Core transducer of GO:0045125 signaling |
| GNAQ | G-protein alpha subunit coupled to bioactive lipid receptors | Core transducer of GO:0045125 signaling |
| GNA13 | G-protein alpha subunit coupled to bioactive lipid receptors | Core transducer of GO:0045125 signaling |
| ARRB1 | Beta-arrestin 1, regulator of G-protein-coupled receptor signaling | Receptor desensitization and trafficking |
How Is bioactive lipid receptor activity Regulated?
Bioactive lipid receptor activity is regulated at multiple levels. Ligand availability is controlled by lipid metabolic enzymes that synthesize and degrade bioactive lipids, so changes in lipid levels directly alter receptor output. At the receptor level, G-protein coupling and nucleotide exchange on the alpha subunit are the defining regulated steps of GO:0045125. Downstream, signaling can be modulated by metabolic pathways such as PPAR-RXR and adiponectin-AMPK axes, which integrate lipid signals with transcriptional and metabolic responses. Beta-arrestin-mediated desensitization and trafficking further tune receptor activity.
bioactive lipid receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ADIPOR1 | Non-alcoholic fatty liver disease | Knockout and overexpression in hepatocyte cell lines and mouse liver |
| PPARG | Type 2 diabetes and insulin resistance | Point-mutation and knockout models in metabolic cell lines |
| FGF21 | Glucose/lipid homeostasis in diabetes | Knock-in reporter and overexpression models |
| RXRA | Diabetic liver lipid metabolism | Knockout and tagged knock-in in liver-derived cells |
| CNR1 | Inflammation and metabolic signaling | Knockout and point-mutation models in immune and neuronal cells |
Metabolic and fatty liver disease
Bioactive lipid receptor activity contributes to metabolic regulation, and its dysregulation is linked to non-alcoholic fatty liver disease and diabetic liver lipid metabolism. Activation of hepatic adiponectin receptor 1-mediated AMPK signaling ameliorates non-alcoholic fatty liver disease in experimental models, showing that lipid-sensing receptor pathways are actionable therapeutic nodes. Multi-omics analysis of diabetic mouse liver further implicates PPAR-RXR signaling in lipid metabolic dysregulation.
Type 2 diabetes and glucose homeostasis
Lipid-sensing and downstream signaling pathways influence insulin sensitivity and glucose/lipid homeostasis. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis, illustrating how modulation of lipid-responsive pathways can improve metabolic outcomes.
Inflammation and immunity
Bioactive lipids regulate immunological responses, and receptors with GO:0045125 activity are central to translating lipid cues into inflammatory and immune signals. Eicosanoids and other lipid mediators produced by enzymes such as PTGS2 and ALOX5 act through lipid-responsive receptors to shape immune cell behavior.
Neurodegeneration and neuroinflammation
Docosahexaenoic acid-derived neurolipids participate in brain lipid signaling, and their dysregulation has been associated with neuroinflammatory and neurodegenerative processes. Endogenous bioactive lipids also modulate ion channels such as TRPV1, providing a structural basis for lipid-receptor crosstalk in sensory and neural systems.
From bioactive lipid receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate receptor required for lipid-induced G-protein activation? | CRISPR knockout of the receptor gene followed by GTP-loading assays |
| Does a specific receptor residue mediate lipid ligand binding? | Point-mutation knock-in of the ligand-binding pocket |
| Can receptor activity be monitored in live cells? | Tagged knock-in of a fluorescent or luminescent reporter |
| Does receptor overexpression amplify lipid signaling? | Stable overexpression in a lipid-responsive cell line |
| Which downstream metabolic genes respond to receptor activation? | Knockout plus RNA-seq and multi-omics profiling |
| Can a lipid-sensing pathway be targeted to treat metabolic disease? | Knockout and overexpression in disease-relevant mouse models |
How to Study the bioactive lipid receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| GTP-loading assay | GDP/GTP exchange on G-alpha subunit | Direct functional readout of GO:0045125 |
| Lipidomics / mass spectrometry | Bioactive lipid species and levels | Ligand availability profiling |
| RNA-seq | Transcriptional responses to receptor activation | Downstream pathway discovery |
| Multi-omics integration | Combined lipid, transcript, and metabolite changes | Systems-level disease modeling |
| CRISPR knockout | Loss-of-function phenotype | Causal gene validation |
| Point-mutation knock-in | Effect of specific receptor residues | Ligand-binding and coupling mechanism |
| Tagged knock-in | Receptor localization and abundance | Live-cell imaging and trafficking |
| Overexpression | Gain-of-function signaling output | Pathway amplification and drug testing |
G-protein activation assays
GTP-loading and GDP/GTP exchange assays directly measure the defining catalytic event of GO:0045125, namely GDP-to-GTP exchange on the G-alpha subunit following lipid ligand binding. These assays can be combined with receptor knockout or point-mutation to establish causality.
Lipid ligand profiling and metabolomics
Mass spectrometry-based lipidomics and metabolomics quantify bioactive lipid levels and identify which lipid species are available to activate receptors. Such profiling is essential because receptor output depends on changes in lipid levels.
Transcriptomic and multi-omics analysis
RNA-seq and integrated multi-omics can reveal downstream transcriptional programs controlled by lipid-responsive pathways, as shown in studies of diabetic mouse liver and PPAR-RXR signaling. These approaches link receptor activity to metabolic gene networks.
Structural and imaging approaches
Structural biology of lipid-modulated receptors, such as TRPV1, reveals how endogenous bioactive lipids interact with receptor domains. Imaging and reporter-based assays can localize receptor activity and track signaling in live cells.
How CRISPR Can Be Used to Study GO:0045125 bioactive lipid receptor activity
Knockout
CRISPR knockout of genes encoding bioactive lipid receptors or their G-protein partners removes the function and allows researchers to test whether a specific lipid-induced response depends on GO:0045125. Knockout models are widely used to validate metabolic and inflammatory phenotypes in cell lines and mice.
Point Mutation
Point-mutation knock-in can alter individual residues in the ligand-binding pocket or G-protein coupling interface, enabling precise structure-function dissection of bioactive lipid receptor activity. Such models are particularly useful when a receptor has multiple lipid ligands or coupling partners.
Knock-in
Tagged knock-in of endogenous receptor loci allows monitoring of receptor expression, localization, and trafficking without overexpression artifacts. Knock-in reporters can also be used to track signaling dynamics in response to bioactive lipids.
Overexpression
Overexpression of a bioactive lipid receptor or its downstream effectors amplifies signaling output and can sensitize cells to lipid ligands, facilitating drug screening and pathway mapping. Overexpression models have been used to demonstrate metabolic benefits of activating lipid-sensing pathways in vivo.
How EDITGENE Supports bioactive lipid receptor activity Research
Researchers studying bioactive lipid receptor activity-related genes often need to determine whether a candidate gene is causally involved in lipid sensing, G-protein coupling, or downstream metabolic and inflammatory responses. EDITGENE provides publication-ready CRISPR cell models and screening services that enable precise, reproducible interrogation of GO:0045125-related biology.
Contact EDITGENE today to design your custom CRISPR model for bioactive lipid receptor activity research.
Frequently Asked Questions About bioactive lipid receptor activity
What is bioactive lipid receptor activity?
Bioactive lipid receptor activity (GO:0045125) is a molecular function in which a receptor binds a bioactive lipid and transmits the signal across the membrane by activating an associated heterotrimeric G-protein, promoting GDP-to-GTP exchange on the alpha subunit.
What is the GO ID for bioactive lipid receptor activity?
The GO ID is GO:0045125, and the ontology aspect is molecular_function.
What genes are involved in bioactive lipid receptor activity?
Genes involved include receptors such as CNR1, CNR2, LPAR1, and S1PR1, G-protein subunits such as GNAI1, GNAQ, and GNA13, and lipid metabolic enzymes such as PTGS2, ALOX5, and PLA2G4A.
What are bioactive lipids?
Bioactive lipids are lipids for which changes in lipid levels result in functional consequences in a variety of cellular processes, including lysophospholipids, endocannabinoids, eicosanoids, and docosahexaenoic acid-derived mediators.
How does bioactive lipid receptor activity signal?
The receptor binds a bioactive lipid and promotes GDP-to-GTP exchange on the alpha subunit of a heterotrimeric G-protein, initiating downstream signaling.
Which diseases are linked to bioactive lipid receptor activity?
Dysregulation is linked to metabolic disorders such as non-alcoholic fatty liver disease and type 2 diabetes, as well as inflammatory and immune conditions.
How can I study bioactive lipid receptor activity in the lab?
Common approaches include GTP-loading assays, lipidomics, RNA-seq, multi-omics, and CRISPR knockout or point-mutation models.
What CRISPR models are used for bioactive lipid receptor research?
Knockout, point-mutation, knock-in, and overexpression models are used to test causal roles of receptors and their downstream effectors.
Is bioactive lipid receptor activity involved in fatty liver disease?
Yes, activation of hepatic adiponectin receptor 1-mediated AMPK signaling ameliorates non-alcoholic fatty liver disease in experimental models, and PPAR-RXR signaling is implicated in diabetic liver lipid metabolism.
Can bioactive lipid receptor activity be targeted therapeutically?
Modulation of lipid-sensing pathways has shown metabolic benefits in mouse models, including improved insulin sensitivity and glucose/lipid homeostasis, supporting therapeutic targeting.
Conclusion
GO:0045125 (bioactive lipid receptor activity) defines the molecular function that converts bioactive lipid cues into heterotrimeric G-protein signaling through GDP-to-GTP exchange on the alpha subunit. This activity is central to inflammation, immunity, and metabolic regulation, and its dysregulation is implicated in fatty liver disease, type 2 diabetes, and related disorders. CRISPR-based knockout, point-mutation, knock-in, and overexpression models, combined with lipidomics and multi-omics, provide a rigorous path to dissect these mechanisms and identify therapeutic targets.
References
- 2. Li Q et al.. 2022. Atractylenolide III ameliorates Non-Alcoholic Fatty Liver Disease by activating Hepatic Adiponectin Receptor 1-Mediated AMPK Pathway.. Int J Biol Sci 18(4):1594-1611 PMID: 35280674
- 3. Chen Y et al.. 2023. Berberine protects mice against type 2 diabetes by promoting PPARγ-FGF21-GLUT2-regulated insulin sensitivity and glucose/lipid homeostasis.. Biochem Pharmacol 218:115928 PMID: 37979703
- 4. Zou J et al.. 2024. Dendrobium officinale regulate lipid metabolism in diabetic mouse liver via PPAR-RXR signaling pathway: Evidence from an integrated multi-omics analysis.. Biomed Pharmacother 173:116395 PMID: 38460364
- 5. Niemoller TD et al.. 2010. Docosahexaenoic acid neurolipidomics.. Prostaglandins Other Lipid Mediat 91(3-4):85-9 PMID: 19804838
- 6. Arnold WR et al.. 2024. Structural basis of TRPV1 modulation by endogenous bioactive lipids.. Nat Struct Mol Biol 31(9):1377-1385 PMID: 38698206
- 7. Maccarrone M. 2023. Deciphering Complex Interactions in Bioactive Lipid Signaling.. Molecules 28(6) PMID: 36985594
- 8. Taketomi Y et al.. 2017. [Immunological Regulation by Bioactive Lipids].. Yakugaku Zasshi 137(5):503-515 PMID: 28458280
